Implications for vancomycin-resistant Enterococcus colonization associated with Clostridium difficile infections

American Journal of Infection Control

Volumn 39, Issue 3, 2011, Pages 188-193

  Fujitani, Shigeki ^a,b   George, W Lance ^c   Morgan, Margie A ^a,d   Nichols, Stephen ^a,d   Murthy, A Rekha ^a,d  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE HOSPITAL   (Japan)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clostridium difficile; multidrug resistant pathogens; vancomycin resistant Enterococcus

Indexed keywords

LEVOFLOXACIN; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; CLOSTRIDIUM DIFFICILE INFECTION; CLOSTRIDIUM INFECTION; CONTROLLED STUDY; DEMENTIA; FECES ANALYSIS; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MIXED INFECTION; MULTIDRUG RESISTANCE; PROSPECTIVE STUDY; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; CARRIER STATE; CLOSTRIDIUM DIFFICILE; ENTEROCOCCUS; FECES; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE;

EID: 79953664434     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2010.10.024     Document Type: Article

References (25)

1. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002;136:834-44. (Pubitemid 34568654)
2. Lawrence SJ, Puzniak LA, Shadel BN, Gillespie KN, Kollef MH, Mundy LM. Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol 2007;28:123-30. (Pubitemid 46374151)
3. Poduval RD, Kamath RP, Corpuz M, Norkus EP, Pitchumoni CS. Clostridium difficile and vancomycin-resistant enterococcus: the new nosocomial alliance. Am J Gastroenterol 2000;95:3513-5.
4. Leber AL, Hindler JF, Kato EO, Bruckner DA, Pegues DA. Laboratory-based surveillance for vancomycin-resistant enterococci: utility of screening stool specimens submitted for Clostridium difficile toxin assay. Infect Control Hosp Epidemiol 2001;22:160-4. (Pubitemid 32233895)
5. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442-9. (Pubitemid 41770165)
6. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:2433-41. (Pubitemid 41770164)
7. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28:140-5. (Pubitemid 46374153)
8. Gardiner D, Murphey S, Ossman E, Jungkind D. Prevalence and acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Infect Control Hosp Epidemiol 2002;23:466-8.
9. Fletcher KR, Cinalli M. Identification, optimal management, and infection control measures for Clostridium difficile-associated disease in long-term care. Geriatr Nurs 2007;28:171-81.
10. Makris AT, Gelone S. Clostridium difficile in the long-term care setting. J Am Med Dir Assoc 2007;8:290-9. (Pubitemid 46877032)
11. Ray AJ, Pultz NJ, Bhalla A, Aron DC, Donskey CJ. Coexistence of vancomycin-resistant enterococci and Staphylococcus aureus in the intestinal tracts of hospitalized patients. Clin Infect Dis 2003;37:875-81. (Pubitemid 37267200)
12. Marra AR, Edmond MB, Wenzel RP, Bearman GM. Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome. BMC Infect Dis 2007;7:42.
13. McNeil SA, Malani PN, Chenoweth CE, Fontana RJ, Magee JC, Punch JD, et al. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis 2006;42:195-203.
14. Russell DL, Flood A, Zaroda TE, Acosta C, Riley MM, Busuttil RW, et al. Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant 2008;8:1737-43.
15. Gerding DN. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clin Infect Dis 1997;25(Suppl 2):S206-10.
16. Salgado CD, Giannetta ET, Farr BM. Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile. Infect Control Hosp Epidemiol 2004;25:413-7. (Pubitemid 38621089)
17. Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126-33.
18. Pultz NJ, Stiefel U, Subramanyan S, Helfand MS, Donskey CJ. Mechanisms by which anaerobic microbiota inhibit the establishment in mice of intestinal colonization by vancomycin-resistant Enterococcus. J Infect Dis 2005;191:949-56. (Pubitemid 40349811)
19. Ray AJ, Hoyen CK, Das SM, Eckstein EC, Donskey CJ. Undetected vancomycin-resistant Enterococcus stool colonization in a Veterans Affairs Hospital using a Clostridium difficile-focused surveillance strategy. Infect Control Hosp Epidemiol 2002;23:474-7.
20. Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol 2007;28:249-60. (Pubitemid 46480722)
21. Lin MY, Hayden MK. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: recognition and prevention in intensive care units. Crit Care Med 2010;38:S335-44.
22. Shadel BN, Puzniak LA, Gillespie KN, Lawrence SJ, Kollef M, Mundy LM. Surveillance for vancomycin-resistant enterococci: type, rates, costs, and implications. Infect Control Hosp Epidemiol 2006;27:1068-75. (Pubitemid 44670983)
23. Centers for Disease Control and Prevention. Healthcare-associated infections (HAIs). C difficile frequently asked questions information for healthcare providers. Available from: http://www.cdc.gov/ncidod/dhqp/id- CdiffFAQ-HCP.html. Accessed October 10, 2010.
24. Dubberke ER, Gerding DN, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(Suppl 1):S81-92.
25. Sethi AK, Al-Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C difficile infection. Infect Control Hosp Epidemiol 2010;31:21-7.